Basic Information
IMOVAX POLIO INJECTION
INJECTION
Regulatory Information
SIN10608P
January 6, 1999
Prescription Only
Therapeutic
SUBCUTANEOUS, INTRAMUSCULAR
August 10, 2023
May 30, 2025
XJ07BF03
Company Information
Active Ingredients
Strength: 32 D.U./0.5 mL
Strength: 8 D.U./0.5 mL
Strength: 40 D.U./0.5 mL
Detailed Information
Contraindications
**Contraindications** Hypersensitivity to the active substances or to any of the excipients listed in section 6.1 – _please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information_, or to any vaccine containing the same substances, to neomycin, streptomycin or polymyxin B. Common transient contraindications to any vaccination: in case of fever or acute illness, it is best to postpone vaccination.
Indication Information
**Therapeutic indications** This vaccine is indicated for the prevention of poliomyelitis in infants, children and adults, for primary and booster vaccination. IMOVAX POLIO must be used according to effective official recommendations.